首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Effect of Electroacupuncture on Hyperalgesia and Vasoactive Neurotransmitters in a Rat Model of Conscious Recurrent Migraine
【2h】

Effect of Electroacupuncture on Hyperalgesia and Vasoactive Neurotransmitters in a Rat Model of Conscious Recurrent Migraine

机译:电针对自觉复发性偏头痛大鼠模型痛觉过敏和血管活性神经递质的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Migraine onset is associated with the abnormal release of vasoactive neurotransmitters from perivascular nerves, and these neurotransmitters are involved in the pathophysiology of migraine. Hyperalgesia is a key feature of migraine, and accumulating evidence indicates that electroacupuncture (EA) at the single acupuncture point (Fengchi [GB20]) is effective in ameliorating hyperalgesia. In clinical practice, multiple acupuncture points are widely used, especially GB20 and Yanglingquan (GB34). However, the role played by vasoactive neurotransmitters in acupuncture antihyperalgesic effect at the single or multiple acupuncture points remains unknown. We aimed to determine whether EA would exert its antihyperalgesic effects by modulating vasoactive neurotransmitter release from the perivascular nerves. Furthermore, we examined whether targeting multiple acupuncture points would be more effective than targeting a single point in reducing hyperalgesia. The mechanical and thermal hyperalgesia were evaluated by measuring the facial and hind-paw mechanical withdrawal thresholds, tail-flick and hot-plate latencies. Plasma concentrations of vasoactive neurotransmitters were determined using rat-specific ELISA kits from jugular vein, including calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP), neuropeptide Y (NPY), pituitary adenylate cyclase-activating polypeptide (PACAP), nitric oxide (NO), and endothelin-1 (ET-1). The result suggested that EA significantly ameliorated the mechanical and thermal hyperalgesia, reduced c-Fos levels in the trigeminal ganglion, and attenuated plasma and dural levels of vasoactive neurotransmitters, especially in the multiple acupuncture points group (GB20+GB34). In conclusion, EA exerts antihyperalgesic effect in a rat model of conscious recurrent migraine, possibly via modulation of the vasoactive neurotransmitters. Furthermore, targeting multiple acupuncture points is more effective than targeting a single point in reducing hyperalgesia.
机译:偏头痛发作与血管周围神经血管活性神经递质的异常释放有关,这些神经递质与偏头痛的病理生理有关。痛觉过敏是偏头痛的关键特征,越来越多的证据表明,单针刺穴位(Fengchi [GB20])的电针(EA)可以有效缓解痛觉过敏。在临床实践中,广泛使用多个穴位,尤其是GB20和杨凌泉(GB34)。然而,在单个或多个穴位上血管活性神经递质在针刺抗痛觉过敏作用中所起的作用仍是未知的。我们旨在确定EA是否会通过调节血管周围神经的血管活性神经递质释放来发挥其抗痛觉过敏作用。此外,我们检查了在减少痛觉过敏方面,针对多个穴位是否比针对单个穴位更有效。通过测量面部和后爪的机械退缩阈值,甩尾和热板潜伏期来评估机械和热痛觉过敏。使用大鼠特异性ELISA试剂盒从颈静脉中测定血管活性神经递质的血浆浓度,包括降钙素基因相关肽(CGRP),P物质(SP),血管活性肠肽(VIP),神经肽Y(NPY),垂体腺苷酸环化酶活化多肽(PACAP),一氧化氮(NO)和内皮素1(ET-1)。结果表明,EA明显改善了机械和热痛觉过敏,降低了三叉神经节的c-Fos水平,并减弱了血浆和硬脑膜的血管活性神经递质水平,尤其是在多个穴位组(GB20 + GB34)中。总之,EA在有意识的复发性偏头痛的大鼠模型中具有抗痛觉过敏作用,可能是通过调节血管活性神经递质来实现的。此外,在减少痛觉过敏方面,针对多个穴位比针对单个穴位更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号